Why Does IGF-1 LR3 Bind Less to IGF-Binding Proteins?
IGF-1 LR3 Pack 1mg
In normal physiology, IGFBPs (there are six known types, IGFBP-1 through IGFBP-6) serve an important regulatory function: they extend IGF-1's half-life in circulation while also controlling how much of it is "free" and able to interact with cell-surface IGF-1 receptors at any given moment. More than 90% of circulating native IGF-1 is bound to IGFBPs, primarily IGFBP-3, in normal human physiology.
Because IGF-1 LR3's N-terminal modification interferes with the specific binding site IGFBPs recognize, published in-vitro binding studies report substantially reduced IGFBP affinity for the analog compared to native IGF-1. The practical research consequence is that a larger proportion of IGF-1 LR3 remains unbound and available to interact with IGF-1 receptors in a research system, which is why the analog is used in studies requiring sustained receptor engagement.
This is a structural-biology explanation, not usage guidance. IGF-1 LR3 is listed on revivelab.ae as the IGF-1 LR3 pack (1 mg); this page describes the compound and gives no guidance on its use.
AED 650 · Lot-specific COA on request · Cash on delivery or USDT (5% off) Order IGF-1 LR3 Pack UAE — Live Stock & Pricing